Your browser doesn't support javascript.
loading
Is additional acid-suppressing agents needed after the initial Helicobacter pylori eradication therapy to heal peptic ulcers? / 대한내과학회지
Korean Journal of Medicine ; : 439-443, 2001.
Article em Ko | WPRIM | ID: wpr-12574
Biblioteca responsável: WPRO
ABSTRACT
BACKGROUND: Helicobacter pylori (H. pylori) can now be eradicated in the majority of patients with 7 days of treatment with OAC (omeprazole+amoxicillin+clarithromycin) regimen. It is unclear if additional acid-suppressing treatment should be continued beyond 7 days in patients with active gastric or duodenal ulcers. METHODS: Ninety two patients with endoscopically proven active peptic ulcers who were H. pylori positive were randomized to receive either omeprazole 20 mg plus amoxicillin 1.0g plus clarithromycin 500mg ; twice daily for 1 week alone (OAC group) or same regimen followed by 3 weeks of omeprazole (OACP group). Endoscopy and UBT (urea breath test) were performed 8 weeks after the initiation of treatment. RESULTS: Forty four of forty five (97.8%) of OAC group and forty four of forty seven (93.6%) of OACP group were noted to have healed ulcer at week 8. CONCLUSION: In patients with H. pylori infection and peptic ulcers, one week of OAC therapy without further need for PPI may heal the ulcers. Following an l week course of H. pylori eradication therapy by OAC for peptic ulcers, further 3 weeks of acid-suppressing therapy with PPI was not proven to promote ulcer healing rate.
Assuntos
Palavras-chave
Texto completo: 1 Índice: WPRIM Assunto principal: Úlcera Péptica / Úlcera / Omeprazol / Helicobacter pylori / Helicobacter / Claritromicina / Úlcera Duodenal / Endoscopia / Amoxicilina Tipo de estudo: Clinical_trials Limite: Humans Idioma: Ko Revista: Korean Journal of Medicine Ano de publicação: 2001 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Assunto principal: Úlcera Péptica / Úlcera / Omeprazol / Helicobacter pylori / Helicobacter / Claritromicina / Úlcera Duodenal / Endoscopia / Amoxicilina Tipo de estudo: Clinical_trials Limite: Humans Idioma: Ko Revista: Korean Journal of Medicine Ano de publicação: 2001 Tipo de documento: Article